DexCom (DXCM) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
DexCom (DXCM) PT Raised to $175 at Cowen Following 4Q Report
February 22, 2019 6:43 AM ESTCowen analyst Doug Schenkel raised the price target on DexCom (NASDAQ: DXCM) to $175.00 (from $150.00) while maintaining a Outperform rating following the company's 4Q. Revenue of $338MM came in $53MM ahead of original consensus expectations and $7MM higher than pre-announced results. Gross margin of... More
